KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt to Equity (2018 - 2025)

Historic Debt to Equity for Esperion Therapeutics (ESPR) over the last 3 years, with Q3 2025 value amounting to -$0.34.

  • Esperion Therapeutics' Debt to Equity changed N/A to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.34, marking a year-over-year change of. This contributed to the annual value of -$0.36 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Esperion Therapeutics' Debt to Equity stood at -$0.34.
  • In the past 5 years, Esperion Therapeutics' Debt to Equity registered a high of -$0.33 during Q1 2025, and its lowest value of -$0.36 during Q4 2024.